References
- Chen Q, Sun Y, Wang J, Yan G, Cui Z, Yin H, Wei H. 2013. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles. Artif Cells Nanomed Biotechnol. doi:https://doi.org/10.3109/2169-1401.2013.845570.
- Hostetter AA, Osborn MF, DeRose VJ. 2012. RNA-Pt adducts formed from cisplatin treatment of Saccharomyces cerevisiae. ACS Chem Biol. 7:218–225.
- King CL, Ramachandran S, Chaney SG, Collins L, Swenberg JA, DeKrafft KE, et al. 2012. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells. Cancer Chemother Pharmacol. 69:666–677.
- Melgar MJ, Alonso J, García MA. 2014. Total contents of arsenic and associated health risks in edible mushrooms, mushroom supplements and growth substrates from Galicia (NW Spain). Food Chem Toxicol. 73C:44–50.
- Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC. 2011. Dose effects of- oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLoS ONE. 6:e18469.
- Sittl R, Lampert A, Huth T, Schuy ET, Link AS, Fleckenstein J, et al. 2012. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current. Proc Natl Acad Sci. 109:6704–6709.
- Wang K, Liu L, Zhang T, Zhu YL, Qiu F, Wu XG, et al. 2011. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer. Int J Nanomedicine. 6:3207–3218.
- Wei H, Xu L, Sun Y, Li G, Cui Z, Yan G, et al. 2014. Preliminary pharmacokinetics of PEGylated oxaliplatin polylactic acid nanoparticles in rabbits and tumor-bearing mice. Artif Cells Nanomed Biotechnol. doi:https://doi.org/10.3109/21691401.2014.883402.
- Weidmann AG, Barton JK. 2014. Construction and application of a rh-pt DNA metalloinsertor conjugate. Inorg Chem. 53: 7812–7814.